Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia

Affiliations

¹ International Network of Hematology, London, UK.
² Department of Clinical Sciences and Community, University of Milan, Milan, Italy.
³ Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. ataher@aub.edu.lb.

Khaled M Musallam et al. Ann Hematol. 2021 Jul.

. 2021 Jul;100(7):1903-1905.

doi: 10.1007/s00277-021-04456-5. Epub 2021 Feb 11.

¹ International Network of Hematology, London, UK.
² Department of Clinical Sciences and Community, University of Milan, Milan, Italy.
³ Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. ataher@aub.edu.lb.

No abstract available

References

1. Taher AT, Musallam KM, Saliba AN, Garziadei G, Cappellini MD (2015) Hemoglobin level and morbidity in non-transfusion-dependent thalassemia. Blood Cells Mol Dis 55:108–109 - DOI
1. Musallam KM, Cappellini MD, Daar S, Taher AT (2021) Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study. Ann Hematol. https://doi.org/10.1007/s00277-020-04370-2
1. Musallam KM, Rivella S, Taher AT (2021) Management of non-transfusion-dependent beta-thalassemia (NTDT): the next 5 years. Am J Hematol 96:E57–59
1. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886–1892 - DOI
1. Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, Taher AT (2011) Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia. Haematologica 96:1605–1612 - DOI